Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

UNC93B1 promotes tumoral growth by controlling the secretion level of granulocyte macrophage colony-stimulating factor in human oral cancer.

Wagai S, Kasamatsu A, Iyoda M, Hayashi F, Hiroshima K, Yoshimura S, Miyamoto I, Nakashima D, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.

Biochem Biophys Res Commun. 2019 May 21;513(1):81-87. doi: 10.1016/j.bbrc.2019.03.172. Epub 2019 Mar 30.

PMID:
30935694
2.

Deficiency of lysyl hydroxylase 2 in mice causes systemic endoplasmic reticulum stress leading to early embryonic lethality.

Kasamatsu A, Uzawa K, Hayashi F, Kita A, Okubo Y, Saito T, Kimura Y, Miyamoto I, Oka N, Shiiba M, Ito C, Toshimori K, Miki T, Yamauchi M, Tanzawa H.

Biochem Biophys Res Commun. 2019 May 7;512(3):486-491. doi: 10.1016/j.bbrc.2019.03.091. Epub 2019 Mar 21.

PMID:
30905411
3.

Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects.

Uzawa K, Kasamatsu A, Saito T, Kita A, Sawai Y, Toeda Y, Koike K, Nakashima D, Endo Y, Shiiba M, Takiguchi Y, Tanzawa H.

Exp Cell Res. 2019 Mar 15;376(2):210-220. doi: 10.1016/j.yexcr.2019.01.016. Epub 2019 Jan 25.

PMID:
30690028
4.

Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer.

Hayashi F, Kasamatsu A, Endo-Sakamoto Y, Eizuka K, Hiroshima K, Kita A, Saito T, Koike K, Tanzawa H, Uzawa K.

Biochem Biophys Res Commun. 2019 Jan 22;508(4):1133-1138. doi: 10.1016/j.bbrc.2018.12.060. Epub 2018 Dec 13.

PMID:
30554657
5.

Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.

Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.

J Cancer. 2018 Sep 7;9(18):3326-3333. doi: 10.7150/jca.25666. eCollection 2018.

6.

FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.

Toeda Y, Kasamatsu A, Koike K, Endo-Sakamoto Y, Fushimi K, Kasama H, Yamano Y, Shiiba M, Tanzawa H, Uzawa K.

Mol Carcinog. 2018 Dec;57(12):1690-1697. doi: 10.1002/mc.22889. Epub 2018 Sep 5.

PMID:
30129678
7.

Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer.

Sawai Y, Kasamatsu A, Nakashima D, Fushimi K, Kasama H, Iyoda M, Kouzu Y, Shiiba M, Tanzawa H, Uzawa K.

Lab Invest. 2018 Aug;98(8):980-988. doi: 10.1038/s41374-018-0070-3. Epub 2018 May 31.

PMID:
29855544
8.

Evidence for critical role of Tie2/Ang1 interaction in metastatic oral cancer.

Kitajima D, Kasamatsu A, Nakashima D, Miyamoto I, Kimura Y, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.

Oncol Lett. 2018 May;15(5):7237-7242. doi: 10.3892/ol.2018.8212. Epub 2018 Mar 8.

9.

Multiple coagulation factor deficiency protein 2 as a crucial component in metastasis of human oral cancer.

Fukamachi M, Kasamatsu A, Endo-Sakamoto Y, Fushimi K, Kasama H, Iyoda M, Minakawa Y, Shiiba M, Tanzawa H, Uzawa K.

Exp Cell Res. 2018 Jul 1;368(1):119-125. doi: 10.1016/j.yexcr.2018.04.021. Epub 2018 Apr 19.

PMID:
29679592
10.

Diacylglycerol lipase alpha promotes tumorigenesis in oral cancer by cell-cycle progression.

Okubo Y, Kasamatsu A, Yamatoji M, Fushimi K, Ishigami T, Shimizu T, Kasama H, Shiiba M, Tanzawa H, Uzawa K.

Exp Cell Res. 2018 Jun 1;367(1):112-118. doi: 10.1016/j.yexcr.2018.03.041. Epub 2018 Mar 31.

PMID:
29614312
11.

Evaluation of tryptophan-aspartic acid repeat-containing protein 34 as a novel tumor-suppressor molecule in human oral cancer.

Yamamoto JI, Kasamatsu A, Okubo Y, Nakashima D, Fushimi K, Minakawa Y, Kasama H, Shiiba M, Tanzawa H, Uzawa K.

Biochem Biophys Res Commun. 2018 Jan 22;495(4):2469-2474. doi: 10.1016/j.bbrc.2017.12.138. Epub 2017 Dec 24.

PMID:
29278705
12.

Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis.

Kita A, Kasamatsu A, Nakashima D, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.

J Cancer. 2017 Jul 5;8(11):2033-2041. doi: 10.7150/jca.18714. eCollection 2017.

13.

Mucoepidermoid carcinoma with extensive spindled morphology and melanocytic marker expression.

Oide T, Hiroshima K, Takahashi Y, Fugo K, Yamatoji M, Kasamatsu A, Endo-Sakamoto Y, Shiiba M, Uzawa K, Tanzawa H, Nagao T, Nakatani Y.

Hum Pathol. 2017 Sep;67:181-186. doi: 10.1016/j.humpath.2017.03.010. Epub 2017 Apr 12.

PMID:
28412212
14.

TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.

Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.

Biochem Biophys Res Commun. 2017 Apr 29;486(2):385-390. doi: 10.1016/j.bbrc.2017.03.050. Epub 2017 Mar 14.

PMID:
28315328
15.

Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity.

Shiiba M, Yamagami H, Yamamoto A, Minakawa Y, Okamoto A, Kasamatsu A, Sakamoto Y, Uzawa K, Takiguchi Y, Tanzawa H.

Oncol Rep. 2017 Apr;37(4):2025-2032. doi: 10.3892/or.2017.5480. Epub 2017 Mar 1.

PMID:
28259989
16.

UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.

Yoshimura S, Kasamatsu A, Nakashima D, Iyoda M, Kasama H, Saito T, Takahara T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.

Biochem Biophys Res Commun. 2017 Apr 15;485(4):820-825. doi: 10.1016/j.bbrc.2017.02.138. Epub 2017 Feb 28.

PMID:
28257844
17.

SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.

Takahara T, Kasamatsu A, Yamatoji M, Iyoda M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.

Exp Cell Res. 2017 Mar 15;352(2):357-363. doi: 10.1016/j.yexcr.2017.02.026. Epub 2017 Feb 22.

PMID:
28237246
18.

Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.

Koide N, Kasamatsu A, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.

Sci Rep. 2017 Feb 23;7:43379. doi: 10.1038/srep43379.

19.

Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.

Ishida S, Kasamatsu A, Endo-Sakamoto Y, Nakashima D, Koide N, Takahara T, Shimizu T, Iyoda M, Shiiba M, Tanzawa H, Uzawa K.

Biochem Biophys Res Commun. 2017 Jan 29;483(1):339-345. doi: 10.1016/j.bbrc.2016.12.142. Epub 2016 Dec 23.

PMID:
28017725
20.

Long-term culture of human odontoma-derived cells with a Rho kinase inhibitor.

Uzawa K, Kasamatsu A, Saito T, Takahara T, Minakawa Y, Koike K, Yamatoji M, Nakashima D, Higo M, Sakamoto Y, Shiiba M, Tanzawa H.

Exp Cell Res. 2016 Sep 10;347(1):232-40. doi: 10.1016/j.yexcr.2016.08.005. Epub 2016 Aug 8.

PMID:
27514999

Supplemental Content

Loading ...
Support Center